Why Am I Gaining Weight?
Obesity Causes, Symptoms & BMI

For years, public health campaigns and commercial diet programs have repeated the same simplistic message: weight gain is a simple mathematical equation of calories in versus calories out, and any failure to lose weight is a failure of personal willpower. If you are gaining weight despite eating normally or cutting back, the default assumption is often that you are simply not trying hard enough.

On patient communities like Reddit, YouTube comments, and metabolic health forums, the question "why am I gaining weight when I eat so little?" is one of the most frequently asked questions. Thousands of individuals express deep frustration with their bodies, describing how their weight continues to creep up despite strict dieting. As a physiatrist (a Physical Medicine and Rehabilitation specialist), I see the physical and metabolic toll this shame-based narrative takes on patients in Vigan. The truth is that weight accumulation is not a moral failing; it is a complex biological disease governed by hormonal, genetic, neurological, and metabolic systems. When these systems are dysregulated, your body is actively directed to store energy as fat, regardless of your willpower.

Why Am I Gaining Weight? The Biology-First Answer

Weight gain is primarily regulated by the brain and the endocrine system, which coordinate energy balance, hunger signals, and fat deposition. The central controller of this process is the hypothalamus, which constantly monitors peripheral signals from the gut, pancreas, and fat tissue to determine when you should eat and how much energy your body should burn.

When your metabolism is healthy, this feedback loop functions smoothly. However, when biological barriers like chronic cellular stress, tissue inflammation, or physical immobility arise, the feedback loop breaks. Your brain receives signals indicating that the body is starving, even when there is abundant fat tissue. The result is a persistent drive to consume energy and a simultaneous downregulation of energy expenditure. This biological lock explains why many patients experience unexplained weight gain even when maintaining a stable, traditional Filipino diet of rice, fish, and vegetables.

Clinical Myth #1: "Weight gain is always a direct result of overeating and laziness."

The Evidence: Neuroimaging studies using functional magnetic resonance imaging (fMRI) demonstrate that individuals with obesity have altered neural activation in the brain's reward and executive control circuits, particularly in response to food cues, which diminishes their voluntary capacity to regulate intake through willpower alone (Li et al., Mol Psychiatry 2023; PMID: 36918706). Obesity is a chronic neurobiological disease, not a behavioral choice. Expecting a patient to cure it through sheer effort is like expecting a patient to lower their blood pressure by thinking about it.

The Four Hormonal Drivers of Unexplained Weight Gain

If your weight continues to climb despite normal food intake, the root cause is frequently a disruption in the chemical messengers that control your metabolism. Four primary hormones dictate whether your body burns fuel or locks it away as fat.

1. Insulin Resistance: The Energy Lock

Insulin Resistance (IR) is defined as a pathological state where cells fail to respond to the hormone insulin, locking glucose out of muscle tissue. Insulin, produced by the pancreas, is the primary hormone responsible for moving glucose out of your bloodstream and into your muscles and organs for energy. In patients with insulin resistance, cells in the skeletal muscle and liver become deaf to insulin's signal. The pancreas compensates by producing even higher levels of insulin (hyperinsulinemia). Because insulin is also the body's primary fat-storage hormone, chronically high insulin levels act as a one-way valve: they force glucose into adipose (fat) cells and prevent those cells from releasing stored fat to be burned. Even in a caloric deficit, your muscles remain starved of energy while your body is structurally locked in fat-storage mode.

2. Leptin Resistance: The Broken Fuel Gauge

Leptin Resistance is defined as the impairment of leptin signaling in the brain, which prevents the body from recognizing that it has sufficient fat stores. Leptin is the satiety hormone, secreted by fat cells. Its biological role is to travel to the hypothalamus and signal that you have sufficient energy stores, reducing appetite and boosting metabolic rate. In obesity, the constant excess of fat tissue leads to a massive, chronic flood of leptin. Over time, the receptors in the hypothalamus become desensitized to this signal—a state known as leptin resistance. Although the body has abundant fat stores, the brain receives no satiety signal. It interprets this lack of signal as starvation, driving intense cravings, food-seeking behavior, and a suppressive effect on resting metabolism.

3. Subclinical Hypothyroidism: The Metabolic Thermostat

Subclinical Hypothyroidism is defined as an elevated thyroid-stimulating hormone (TSH) level with normal free thyroid hormone levels, indicating early thyroid gland underactivity. Thyroid hormones (T3 and T4) serve as the primary thermostat for every cell in your body, regulating the rate of mitochondrial oxygen consumption and heat production (thermogenesis). In subclinical hypothyroidism—frequently defined by elevated thyroid-stimulating hormone (TSH) levels between 4.5 and 10.0 mIU/L alongside normal free thyroxine (FT4)—the Basal Metabolic Rate (BMR), defined as the baseline number of calories required to keep your body functioning at rest, drops by approximately 15% to 25%. This drop is driven by the downregulation of uncoupling protein 1 (UCP1) in brown adipose tissue and reduced oxidative capacity in skeletal muscles. Consequently, the energy required to maintain basic life functions is severely reduced, making weight gain inevitable even on a modest caloric intake.

4. Cortisol Excess: The Visceral Fat Magnet

Cortisol Excess is defined as a state of chronically elevated cortisol levels, typically driven by prolonged stress, sleep disruption, or adrenal dysfunction. Cortisol is the body's primary stress hormone, regulated by the hypothalamic-pituitary-adrenal (HPA) axis. Under chronic psychological stress, sleep fragmentation, or conditions like Cushing's syndrome, cortisol levels remain persistently elevated. Cortisol stimulates lipogenesis (fat production) and directly upregulates the activity of lipoprotein lipase (LPL), an enzyme that pulls fat out of the blood and stores it in fat cells. Crucially, visceral fat cells (the deep abdominal fat around your organs) express significantly more glucocorticoid receptors than subcutaneous fat (the fat under your skin). Chronically high cortisol selectively deposits fat in the abdomen, creating a high-risk metabolic profile even if your arms and legs remain thin.

Obesity Causes and Effects: What Is Happening Inside Your Body

Obesity is not merely a cosmetic condition of excess weight; it is a systemic, low-grade inflammatory disease that alters the structure and function of nearly every organ system in the human body.

The primary driver of these systemic effects is the behavior of dysfunctional adipose tissue. When fat cells expand beyond their mechanical and vascular limits, they become hypoxic (deprived of oxygen) and undergo cellular stress. This stress triggers the infiltration of immune cells (macrophages) into the fat tissue, transforming it from an inert energy storage depot into an active endocrine organ that continuously secretes pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and resistin. These cytokines enter the systemic circulation, driving widespread insulin resistance, promoting arterial plaque formation, and damaging blood vessel linings.

At the same time, obesity-induced ectopic lipid deposition occurs when excess fat spills out of standard fat cells and accumulates in places it doesn't belong—namely, the liver, heart, and pancreas. Ectopic fat in the liver drives MASLD (formerly NAFLD), which now affects up to 70-80% of adults with clinical obesity (Tilg et al., JAMA 2025; PMID: 41212550). In the musculoskeletal system, this fat accumulation occurs within the muscles themselves (myosteatosis). Myosteatosis is defined as the infiltration of fat tissue into skeletal muscles, degrading muscle quality, impairing functional mobility, and increasing joint instability.

Content Gap Block: Visceral Fat Dynamics: Visceral Fat is defined as the deep abdominal fat that wraps around internal organs. Many standard health assessments rely solely on standard blood panels and basic waist measurements, which completely miss the distinction between subcutaneous fat (which sits harmlessly under the skin) and visceral fat. Visceral fat behaves like an aggressive, inflammatory endocrine organ, draining directly into the portal vein and flooding the liver with free fatty acids. This process disrupts hepatic insulin clearance and drives systemic insulin resistance. Because visceral fat can accumulate silently behind a firm abdominal wall, a patient can have a relatively flat profile or look superficially healthy while harboring dangerous visceral adiposity that drives cardiovascular risk. Relying on basic visual inspection or standard scales misses this silent metabolic risk factor entirely.

Symptoms of Obesity: What a Physiatrist Actually Evaluates

In clinical medicine, obesity is not defined by cosmetic appearance or clothing size. A comprehensive physiatric evaluation focuses on the metabolic, functional, and mechanical symptoms that compromise a patient's health and mobility.

When I evaluate a patient for obesity at TeraCare Vigan, I look for a cluster of clinical markers:

• Central Adiposity: A waist circumference of ≥80 cm for Filipino women and ≥90 cm for Filipino men is the established WHO threshold for cardiometabolic risk in Asian populations.
• Functional Impairments: Dyspnea (shortness of breath) during simple daily tasks, such as walking to the local Vigan market or climbing a single flight of stairs.
• Biomechanical Joint Pain: Localized joint load pain—most commonly felt as a stiff or heavy sensation in the limbs, radiating pain down the legs (sciatica), or a sharp, catching, or grinding sensation in the knees (crepitus) or hips that worsens with standing or walking.
• Neurological Symptoms: Progressive tingling or burning in the feet, which can signify metabolic nerve irritation or peripheral neuropathy diagnosed via EMG/NCV.
• Sleep Fragmentation: Chronic snoring, waking up gasping for air, morning headaches, and severe daytime sleepiness, indicating potential obstructive sleep apnea.
• Metabolic Marker Clusters: Elevated fasting glucose, insulin levels, triglycerides, and blood pressure, combined with low HDL cholesterol.

Clinical Myth #2: "The primary symptom of obesity is simply looking overweight."

The Evidence: Clinical guidelines emphasize that the functional limitations and joint pain associated with obesity are not just secondary complaints but primary symptoms of systemic tissue dysfunction. In patients with knee osteoarthritis, every 1 kg of excess body weight multiplies joint compressive forces by 4 kg during daily walking, translating small weight changes into massive changes in cartilage wear-and-tear and pain levels (Katz et al., JAMA 2021; PMID: 33560326). Evaluating obesity without assessing joint function, muscle quality, and mobility limitations ignores the very symptoms that impact a patient's quality of life.

Why the BMI Calculator Is Mathematically Flawed

The Body Mass Index (BMI) is the most widely used tool to classify weight status, calculated by dividing a person's weight in kilograms by the square of their height in meters ($kg/m^2$). However, as a clinical tool for individual patients, the standard BMI calculator is mathematically flawed.

First, BMI was derived in the 19th century by Adolphe Quetelet, a Belgian statistician, using data from European soldiers to describe the 'average man.' It was never designed as a diagnostic tool for individual health. Because it only evaluates a simple ratio of weight to height, BMI cannot distinguish between fat mass and lean muscle mass. A highly muscular individual or an athlete may be classified as 'obese' on a BMI scale, while a sedentary patient with low muscle mass and high visceral fat may register as 'normal weight.'

Second, and most critically for our patients in Vigan, standard global BMI cutoffs (overweight at 25, obese at 30) fail Filipino and other Asian populations. Due to genetic variations in adipose tissue distribution, Asians have a higher percentage of body fat, particularly dangerous visceral fat, at equivalent BMI levels compared to Western populations. Consequently, the World Health Organization (WHO) and the Philippine Association for the Study of Overweight and Obesity (PASOO) utilize adjusted Asia-Pacific BMI cutoffs:

• Underweight: < 18.5
• Normal Range: 18.5 to 22.9
• Overweight (Pre-Obese): 23.0 to 24.9
• Obese Class I: 25.0 to 27.4
• Obese Class II (High Risk): ≥ 27.5

This means a Filipino patient with a BMI of 26.0 is not merely 'slightly overweight'—they are clinically obese and facing a significant risk of metabolic cardiovascular disease.

Content Gap Block: Flawed Population Cutoffs: Relying on standard Western BMI cutoffs to screen Filipino patients for metabolic risk is a clinical error. Large cohort studies in Asian populations show that the risk of developing Type 2 diabetes and cardiovascular disease begins to rise exponentially at a BMI of just 22.0. By the time a Filipino patient reaches a standard BMI of 25.0, their relative risk of diabetes is up to three times higher than a Western counterpart with the same score (WHO Expert Consultation, Lancet 2004). In clinic, patients are frequently dismissed as 'healthy' because their BMI is under 25, delaying critical metabolic interventions until cardiovascular damage has already occurred.

What Is Metabolic Syndrome?

Metabolic syndrome is a dangerous cluster of cardiovascular and metabolic abnormalities that occur together, dramatically increasing your risk of developing Type 2 diabetes, stroke, and heart disease.

To be diagnosed with metabolic syndrome, a patient must present with three or more of the following five clinical criteria:

1. Abdominal Obesity: Waist circumference ≥80 cm for Asian women, and ≥90 cm for Asian men.
2. Elevated Triglycerides: ≥150 mg/dL (or active treatment for high triglycerides).
3. Reduced HDL ('Good') Cholesterol: <40 mg/dL for men, and <50 mg/dL for women.
4. Elevated Blood Pressure: Systolic ≥130 mmHg and/or diastolic ≥85 mmHg (or active use of blood pressure medication).
5. Elevated Fasting Glucose: ≥100 mg/dL (or active treatment for pre-diabetes/diabetes).

According to Philippine National Nutrition and Health Survey (NNHeS) data, metabolic syndrome affects approximately 3 in 10 Filipino adults. It is the underlying engine behind the rising rates of cardiovascular disease in the country. Because the syndrome can develop quietly without causing obvious pain, many patients remain undiagnosed until they experience a cardiovascular crisis.

Clinical Myth #3: "If my BMI is in the normal range, I do not have to worry about metabolic syndrome or diabetes."

The Evidence: Clinical studies identify a specific phenotype known as Metabolically Obese Normal Weight (MONW)—individuals who have a normal BMI (<23.0 for Asians) but present with high levels of visceral fat, low muscle mass, insulin resistance, and metabolic syndrome components. Visceral fat accumulation behaves as an independent predictor of cardiometabolic risk, meaning a patient can be visually lean while harboring the same inflammatory and cardiovascular dangers as a patient with overt obesity (Look et al., Diabetes Obes Metab 2025; PMID: 39996356). True metabolic health must be measured through tissue composition and blood chemistry, not simple height-weight ratios.

Genetics, Epigenetics & The Family Weight Pattern

Many patients struggle with the feeling of inevitability because weight gain runs in their family. Twin and family studies confirm that the heritability of obesity is high, estimating that genetics account for 40% to 70% of the variance in body mass index.

More than 1,000 common genetic variants are linked to weight regulation. These genes control physiological pathways such as energy expenditure, appetite regulation, and fat cell storage. For example, variations in the FTO (fat mass and obesity-associated) gene can alter hypothalamic leptin signaling, predisposing individuals to increased hunger and a preference for energy-dense foods.

However, genetics is not destiny. The rapid rise in global obesity rates over the last few decades cannot be explained by changes in our DNA sequence alone. This is where epigenetics—environmental factors that turn genes on or off without altering the genetic code—plays a critical role. Factors such as chronic maternal nutritional deprivation during pregnancy, chronic sleep fragmentation, high exposure to ultra-processed foods, and high stress levels can trigger epigenetic changes (like DNA methylation) that program the offspring's metabolism to favor energy conservation and fat accumulation. Your family history may load the metabolic gun, but your environment, chronic stress, and lifestyle trigger it.

Clinical Body Composition Analysis: The Only True Measure

Because scales and BMI calculators are highly flawed tools, a modern obesity medicine program must utilize clinical body composition analysis to assess health accurately.

At TeraCare Vigan, we use multi-frequency Bioelectrical Impedance Analysis (BIA) to measure body composition. BIA works by sending weak, safe electrical currents through the body. Because different tissues—muscle, fat, bone, and water—have different resistance (impedance) properties, the machine can calculate the exact proportions of each tissue in your body.

This provides several critical clinical metrics:

• Visceral Fat Area: The precise level of deep abdominal fat surrounding organs. A level above 10 indicates high metabolic risk.
• Skeletal Muscle Mass (SMM): The total weight of your skeletal muscle. Our clinical goal is to protect and build this tissue.
• Segmental Lean Analysis: Measures the distribution of muscle across your arms, legs, and trunk, helping us identify muscle imbalances that load arthritic joints.
• Percent Body Fat (PBF): The actual percentage of your weight that is fat, which is a far more reliable indicator of health risk than BMI.

Clinical Myth #4: "Rapid weight loss is always a successful outcome."

The Evidence: Systematic reviews of diet-induced weight loss demonstrate that aggressive, unmonitored caloric restriction results in up to 25% to 40% of the lost weight coming from lean muscle mass rather than fat tissue (Johnston et al., Nutrients 2022; PMID: 36014871). This rapid muscle loss reduces the basal metabolic rate, impairs joint stability, and leads to sarcopenic obesity. A successful weight management program must use serial body composition monitoring to ensure that weight loss is derived strictly from fat while preserving or building skeletal muscle.

What to Do Right Now: Evidence-Based First Steps

If you are ready to address unexplained weight gain and insulin resistance, you do not need to start with high-intensity workouts or severe, unsustainable diets. You can take immediate, safe steps at home to start resetting your metabolism.

Tactical Home Care Pivot: The Insulin Reset Protocol

Instead of following the standard online advice to "eat less rice and jog daily," which frequently fails due to joint pain and metabolic compensation, follow this biomechanics-backed metabolic protocol:

1. Eat Protein First: Ensure that every meal begins with a portion of protein (like eggs, fish, chicken, or tofu) before you consume any carbohydrates. Consuming protein first stimulates the secretion of satiety hormones (GLP-1 and PYY) and slows gastric emptying, significantly reducing the postprandial insulin spike of the meal.
2. Weave in Fiber: Eat fiber-rich vegetables before your rice. Fiber forms a viscous gel-like mesh along the lining of your small intestine. This mesh acts as a mechanical barrier, slowing glucose absorption and blunting the pancreatic insulin response. You do not need to eliminate rice; you simply need to change the order in which you eat your food.
3. The 10-Minute Post-Meal Walk: Perform a gentle, 10-minute walk within 20 minutes after completing your main meals. Post-meal walking activates the contraction of large muscle groups in your legs. This muscular contraction stimulates GLUT4 glucose transporter translocation to the cell membranes, pulling glucose out of your bloodstream independently of insulin. This simple action directly unloads the pancreas and reduces fat storage.
4. Prioritize Sleep Before 11 PM: Go to bed early. Sleep restriction to fewer than six hours per night triggers hypothalamic-pituitary-adrenal axis activation, elevating cortisol levels and suppressing leptin. Prioritizing a consistent sleep schedule lowers cortisol and restores morning insulin sensitivity without costing a single peso.

Clinical Reasoning

Each of these steps targets the physiological drivers of insulin resistance and HPA axis activation. By blunting post-meal glucose spikes, activating non-insulin-mediated glucose uptake in muscles, and reducing cortisol, this protocol helps lower circulating insulin levels. This unlocks stored fat cells to be burned for energy, protecting your resting metabolic rate and joint load tolerance.

Evidence-to-Practice Translation

While clinical guidelines strongly recommend a comprehensive metabolic laboratory workup and frequent body composition monitoring to guide obesity management (Tilg et al., JAMA 2025; PMID: 41212550), the practical reality for patients in Vigan and surrounding Ilocos Sur communities is that these private laboratory tests represent a significant out-of-pocket financial burden, frequently costing upwards of PHP 4,000. In my practice at TeraCare Vigan, rather than demanding an expensive, comprehensive panel upfront, we sequence these diagnostics based on clinical priority: we prioritize fasting glucose, HbA1c, and a basic lipid panel at the initial visit, and delay advanced hormonal screening (such as fasting insulin or TSH) unless the patient's initial response to lifestyle changes indicates a refractory roadblock. I closely monitor safety markers—specifically blood pressure trends, orthostatic symptoms, and changes in joint pain—during the initial phase. If a patient presents with progressive joint load pain (VAS score > 6/10) or fails to show metabolic progress after 12 weeks of structured lifestyle modification, this serves as our clinical threshold to escalate care, coordinating with endocrinology partners or introducing targeted pharmacotherapy (such as GLP-1 receptor agonists) to protect joint cartilage and restore metabolic health.